Videos about MMN

Subcutaneous Immunoglobulins (SCIg) in Responders to Intravenous Immunoglobulins (IVIg) with Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) and Multifocal Motor Neuropathy (MMN)
Nabil Moumane, MD
Medical Affairs and Pharmacology, CSL Behring
3:00 MIN
  • CIDP
  • MMN

Hear why SCIg may be a better option for long-term treatment of patients on Immunoglobulin therapy with difficult venous access.

DOWNLOAD PDF
Electrophysiologic Findings In Multifocal Motor Neuropathy
Jonathan S. Katz, MD
Forbes Norris MDA/ALS Research Center at the California Pacific Medical Center in San Francisco, California
09:15 MIN
  • MMN
Explore electrophysiologic findings of MMN in addition to the classical electrophysiological conduction block
DOWNLOAD PDF
SCIg in Multifocal Motor Neuropathy
Hans D. Katzberg, MD, MSc, FRCP(C)
University Health Network /Toronto General Hospital Canada
10:32 MIN
  • MMN

Hear the results of a trial to determine the feasibility of switching patients with multifocal motor neuropathy on intravenous to subcutaneous immunoglobulin.

DOWNLOAD PDF
Global Multifocal Motor Neuropathy Quality of Life Patient Survey
Jonathan S. Katz, MD
Forbes Norris MDA/ALS Research Center at the California Pacific Medical Center in San Francisco, California
09:51 MIN
  • MMN
Examine a quality of life patient study that identifies needs in education and treatment for patients with MMN.
DOWNLOAD PDF
NOW PLAYING
3:00
Subcutaneous Immunoglobulins (SCIg) in Responders to Intravenous Immunoglobulins (IVIg) with Chronic...

Hear why SCIg may be a better option for long-term treatment of patients on Immunoglobulin therapy with difficult venous access.

NOW PLAYING
09:15
Electrophysiologic Findings In Multifocal Motor Neuropathy
Explore electrophysiologic findings of MMN in addition to the classical electrophysiological conduction block
NOW PLAYING
10:32
SCIg in Multifocal Motor Neuropathy

Hear the results of a trial to determine the feasibility of switching patients with multifocal motor neuropathy on intravenous to subcutaneous immunoglobulin.

NOW PLAYING
09:51
Global Multifocal Motor Neuropathy Quality of Life Patient Survey
Examine a quality of life patient study that identifies needs in education and treatment for patients with MMN.

Our Experts on MMN

Jeffrey A. Allen, MD
University of Minnesota
Jeffrey A. Allen, MD
University of Minnesota
  • CIDP
  • MMN
Dr. Jeffrey Allen is a neuromuscular specialist and clinical investigator at the University of Minnesota in Minneapolis.
Claudia Sommer, MD
University of Würzburg, Würzburg, Germany
Claudia Sommer, MD
Claudia Sommer, MD
University of Würzburg, Würzburg, Germany
  • MMN
Claudia Sommer is a Professor of Neurology at the University of W├╝rzburg, Germany.
Richard A. Lewis, MD
Cedars-Sinai Medical Center, Los Angeles, CA, USA
Richard A. Lewis, MD
Richard A. Lewis, MD
Cedars-Sinai Medical Center, Los Angeles, CA, USA
  • CIDP
  • GBS
  • MMN
Richard A. Lewis, MD is Professor of Neurology at Cedars-Sinai Medical Center in Los Angeles, California where he directs the EMG laboratory and co-directs the neuromuscular clinical program.
Hans D. Katzberg, MD, MSc, FRCP(C)
University Health Network /Toronto General Hospital Canada
Hans D. Katzberg, MD, MSc, FRCP(C)
Hans D. Katzberg, MD, MSc, FRCP(C)
University Health Network /Toronto General Hospital Canada
  • MMN
Dr. Hans Katzberg is a neuromuscular specialist and clinical investigator at the University Health Network / Toronto General Hospital and has been on faculty at the University of Toronto as Assistant Professor of Neurology.
What is Multifocal Motor Neuropathy (MMN)?
READ MORE
What are the symptoms of MMN?
READ MORE
How is MMN treated?
READ MORE

Slides & Posters about MMN

Subcutaneous Immunoglobulins (SCIg) in Responders to Intravenous Immunoglobulins (IVIg) with Chronic Inflammatory Demyelinating Polyradiculo...
PDF | 2.3 MB
Optimizing IgG Therapy in Chronic Autoimmune Neuropathies
PDF | 3.4 MB
SCIg in Multifocal Motor Neuropathy
PDF | 1.2 MB
Pathogenesis and Mechanism of Action of Inflammatory Neuropathies
PDF | 680 KB
Back to Top